THE LATEST

Grabar Law Office Files Class Action on Behalf of Retail Investors Against Certain Investment Firms and Hedge Funds for Violations of Antitrust and Consumer Protection Laws

By Grabar Law | Feb 5, 2021

As alleged in the complaint, several large hedge funds and investment firms, including Citadel Enterprise Americas LLC, Citadel Securities LLC, ...

Grabar Law Office Files Antitrust Class Action Against Google For Alleged Anticompetitive Campaign In The Display Ad Stack Market

By Grabar Law | Feb 3, 2021

The Complaint is brought on behalf of similarly situated publishers that sold digital Display Ad inventory through Google’s AdSense targeting ...

Joshua H. Grabar Featured In International Municipal Lawyers Association’s (IMLA) Blog Regarding The Role of Municipalities in Corporate Governance With Respect to Diversity and Inclusion.

By Grabar Law | Feb 2, 2021

Municipal entities are increasingly recognizing their ability to influence social change through demanding better corporate governance from the companies in ...

Grabar Law Office Files Motion to Intervene on Behalf of the State of Louisiana to Recover Settlement Funds

By Grabar Law | Jan 22, 2021

As alleged in its motion and proposed accompanying complaint, Plaintiff, the State of Louisiana, brought its action with respect to ...

Joshua H. Grabar’s Article, “Shareholder Litigation in The Age of Financial and Social Responsibility,” is Published by Engaging Local Government Leaders (ELGL)

By Grabar Law | Jan 12, 2021

In securities class actions, plaintiffs bring a suit as a class seeking compensation from defendants for damages resulting from a ...

Grabar Law Office Files Complaint Pursuant to 8 DEL. C. § 220 to Compel Inspection of Books and Records of Zuora, Inc.

By Grabar Law | Dec 31, 2020

The Complaint follows a Section 220 Demand Letter (the “Demand”) served Defendant and Tien Tzuo (“Tzuo”), Zuora’s Chief Executive Officer ...

Grabar Law Office Files Complaint Pursuant to 8 DEL. C. § 220 to Compel Inspection of Books and Records of CV Sciences, Inc.

By Grabar Law | Nov 27, 2020

Plaintiff brings this action pursuant to 8 Del. C. § 220 (“Section 220”) to enforce Plaintiff’s statutory right to inspect ...

Grabar Law Office Recognized as Top Commercial Litigation Firm

By Grabar Law | Nov 20, 2020

Grabar Law Office is pleased to have been selected as "Best Commercial Litigation Firm - Pennsylvania" for 2020. "Grabar Law ...

Blue Health Insurers Reach Tentative Antitrust Settlement For $2.7 Billion

By Grabar Law | Sep 30, 2020

A tentative settlement has been negotiated with The Blue Cross Blue Shield insurance group to end a sweeping antitrust suit ...

Google’s Parent Alphabet Inc. Pledges $310 Million To Expand Diversity Efforts and Resolve Shareholder Litigation

By Grabar Law | Sep 30, 2020

Google's parent Alphabet Inc. pledged $310 million to expand diversity efforts and resolve shareholder litigation that alleged the company’s board ...

« Previous
1
…
6
7
8
9
10
…
16
Next »

Grabar Law Office In the News: Alto Neuroscience Execs Sued Over Rosy Drug Claims

By Grabar Law | Oct 9, 2025

An Alto Neuroscience investor claims CEO Amit Etkin and other directors overstated the efficacy of the psychiatric biotech company's lead ...

Grabar Law Office In the News: Marijuana Vape Antitrust Actions Consolidated In Calif.

By Grabar Law | Oct 9, 2025

Five proposed antitrust class actions brought by buyers of CCell brand cannabis vape accusing the Chinese manufacturers and U.S. distributors ...

Grabar Law Office In the News: DOJ Asks for Stay in PVC Antitrust Case Amid Criminal Probe

By Grabar Law | Oct 9, 2025

The U.S. Department of Justice is asking an Illinois federal court to pause discovery in a case accusing polyvinyl chloride ...

Grabar Law Office In the News: Biotech Replimune Faces Derivative Suit Over Trial Claims

By Grabar Law | Aug 26, 2025

Executives and directors of biotechnology company Replimune Group Inc. face shareholder derivative claims that they concealed issues affecting a clinical ...

Grabar Law Office In the News: Biotech Replimune Faces Derivative Suit Over Trial Claims

By Grabar Law | Aug 26, 2025

Executives and directors of biotechnology company Replimune Group Inc. face shareholder derivative claims that they concealed issues affecting a clinical ...

Grabar Law Office Files Federal Lawsuit Against Major Insulin Manufacturers and PBMs on Behalf of the University of Pennsylvania

By Grabar Law | Jul 11, 2025

Grabar Law Office has filed a complaint on behalf of The Trustees of the University of Pennsylvania in the United ...

Grabar Law Office In the News: Geron Shareholder Sues Execs Over Drug Launch Claims

By Grabar Law | Apr 19, 2025

A shareholder of Geron Corp. has filed a derivative suit against current and former members of the biopharmaceutical company's top ...

Grabar Law Office In the News: AI Audio Co. Brass Accused of Acquisition Accounting Errors

By Grabar Law | Apr 19, 2025

Executives and directors of California-based voice recognition technology company SoundHound Inc. were hit with a shareholder derivative suit alleging they ...